NEULASTA 6 mg, 1 pre-filled syringe

Neulasta 6 mg is a prescription medicine used to help reduce the risk of infection caused by a low white blood cell count in certain patients receiving chemotherapy. It contains pegfilgrastim, a long-acting medicine that stimulates the bone marrow to produce more neutrophils, a type of white blood cell that helps the body fight infections.

Neulasta is generally supplied as a single-use pre-filled syringe and must be used according to the treating healthcare professional’s instructions.

What Is Neulasta Used For?

Neulasta is used mainly to reduce the duration of neutropenia and the risk of febrile neutropenia in patients receiving certain chemotherapy regimens that may cause a significant decrease in neutrophils.

Febrile neutropenia is a potentially serious condition involving a low neutrophil count together with fever. The need for treatment depends on the type of cancer, chemotherapy regimen, and individual risk factors.

Active Ingredient

– Pegfilgrastim — 6 mg in 0.6 ml of solution for injection.

How Does Neulasta Work?

Pegfilgrastim is a long-acting granulocyte colony-stimulating factor (G-CSF). It stimulates the bone marrow to produce more neutrophils, helping the body fight infections and reducing the duration of low neutrophil counts following certain chemotherapy treatments.

How to Use Neulasta

• The usual adult dose is one 6 mg subcutaneous injection per chemotherapy cycle, as prescribed by the treating specialist.

• It is generally administered at least 24 hours after the completion of chemotherapy.

• The injection may be given by a trained patient or caregiver if the healthcare team has provided appropriate instructions.

• Do not inject it yourself unless you have been trained to use the pre-filled syringe.

• Follow the prescribed schedule; do not change the dose or timing without consulting your oncology team.

Possible Side Effects

Common or important side effects may include:

• Bone pain and muscle pain.

• Headache.

• Pain at the injection site.

• Nausea.

• Changes in blood counts.

Seek urgent medical attention for severe or persistent pain in the upper left abdomen or left shoulder, difficulty breathing, swelling of the face or throat, or signs of a serious allergic reaction. Fever or other signs of infection during chemotherapy also require prompt medical advice. Rare but serious complications can occur, including spleen rupture and acute respiratory distress.

Warnings and Precautions

• Do not use Neulasta if you are allergic to pegfilgrastim, filgrastim, or any of its ingredients.

• Tell your doctor if you have a history of spleen problems, sickle cell disease, or serious lung problems.

• Inform your healthcare team about all medicines you take and any previous severe allergic reactions.

• Neulasta is not intended for every type of blood cancer or bone marrow disorder; its suitability must be determined by a specialist.

• Seek immediate medical help if you develop symptoms suggesting a serious allergic reaction or spleen complication.

Storage

Store Neulasta in a refrigerator at 2°C to 8°C. Do not freeze it. Keep the syringe in its original carton to protect it from light, and follow the package leaflet for any permitted room-temperature storage period. Keep out of the reach of children.

Frequently Asked Questions

What is Neulasta 6 mg used for?

It helps reduce the duration of low neutrophil counts and the risk of febrile neutropenia in certain patients receiving chemotherapy.

How often is Neulasta given?

It is usually administered as one 6 mg injection per chemotherapy cycle, according to the oncology team’s instructions.

Is Neulasta a chemotherapy medicine?

No. It is a supportive treatment used alongside certain chemotherapy regimens to help the body recover its neutrophil count.

Can Neulasta be self-administered?

Yes, in appropriate circumstances, but only after training from a healthcare professional and in accordance with the product instructions.

Neulasta 6 mg/0.6 ml is a prescription injection containing pegfilgrastim, used to reduce chemotherapy-related neutropenia and the risk of febrile neutropenia in eligible patients. It supports neutrophil production and must be used according to the treating specialist’s instructions, with appropriate monitoring for side effects.

https://pharmatoo.com/product-category/pharmacy/homeopathy-pharmacy/

Tags

• Neulasta 6 mg

• pegfilgrastim

• Neulasta injection

• pre-filled syringe

• neutropenia treatment

• febrile neutropenia prevention

• chemotherapy support

• white blood cell support

• oncology medicine

• prescription medicine